Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer
| Contribuinte(s) |
University of Aberdeen, Medicine, Medical Sciences & Nutrition, Medical Sciences |
|---|---|
| Data(s) |
05/08/2016
05/08/2016
02/05/2016
|
| Resumo |
Financial support: This research was supported by grants to MDS from the NCI (2R01CA105304), the Canadian Institutes of Health Research (MOP79308) and the US Army Medical Research and Materiel Command Prostate Cancer Research Program (E81XWH-11-1-0551). Research by IJM’s group was supported by the Chief Scientist’s Office of the Scottish Government (ETM-258 and -382). We are grateful to Country Meadows Senior Men’s Golf Charity Classic for financial support of this research. Peer reviewed Postprint |
| Identificador |
Yang , Y C , Banuelos , C A , Mawji , N R , Wang , J , Kato , M , Haile , S , McEwan , I J , Plymate , S & Sadar , M D 2016 , ' Targeting androgen receptor activation function-1 with EPI to overcome resistance mechanisms in castration-resistant prostate cancer ' Clinical Cancer Research . , 10.1158/1078-0432.CCR-15-2901 1078-0432 PURE: 65918540 PURE UUID: 3712c05c-8129-47e7-95ea-db55a4a528b8 |
| Idioma(s) |
eng |
| Relação |
Clinical Cancer Research |
| Palavras-Chave | #androgen receptor #N-terminal domain #EPI #castration-resistant prostate cancer #resistance mechanisms #RC0254 Neoplasms. Tumors. Oncology (including Cancer) #Chief Scientist Office (CSO) #ETM-258 #ETM-382 #RC0254 |
| Tipo |
Journal article |
